GLOW
Also known as GLOW blend, GHK-Cu/BPC-157/TB-500 blend
Pre-mixed three-peptide blend of GHK-Cu, BPC-157 and TB-500 for skin and tissue repair.
Medical status: Not approved as a medicine; sold as a research blend.
Also commonly used for (off-label)
- Skin quality, fine lines and hair
- General soft-tissue recovery
- Running GHK-Cu, BPC-157 and TB-500 from one vial
Off-label and research uses are what people report, not approved indications. Talk to a clinician before using any of them.
How it's taken (route)
a small shot into the fat just under the skin (belly, thigh, or love handle)
New to peptides? Start with the beginner's guide.
- Documented dose
- 2000–2500 mcg
- Typical frequency
- Once daily, subcutaneous
- Cycle
- 6 weeks on, 4 off
- Half-life
- Varies by component (GHK-Cu ~1 hour, BPC-157 ~4 hours)
- Common vial sizes
- 50 mg, 70 mg, 100 mg
- Regulatory status
- Not approved for human use; sold as a research compound.
Dose on a U-100 syringe (2000–2500 mcg)
| Vial | BAC water | Draw |
|---|---|---|
| 50 mg | 3 mL | 12–15 units |
| 50 mg | 5 mL | 20–25 units |
| 70 mg | 3 mL | 8.6–11 units |
| 70 mg | 5 mL | 14–18 units |
| 100 mg | 3 mL | 6.0–7.5 units |
| 100 mg | 5 mL | 10–13 units |
On a U-100 syringe, 100 units = 1 mL, and the syringe holds 100 units total. Most people keep a single subcutaneous injection under about 50 units — bigger volumes are usually mixed stronger (less water) or split into two shots. Only mixes that fit in one syringe are shown. Always double-check with the reconstitution calculator.
What it does
GLOW puts three repair peptides in one vial. GHK-Cu is the dominant component and is tied to collagen, elastin and skin quality; BPC-157 is studied for soft-tissue and gut repair; TB-500 is studied for cell migration and wound closure. People typically run it for skin, hair and general recovery goals.
Mechanism
GHK-Cu signals fibroblasts and upregulates collagen-related gene expression, BPC-157 is associated with VEGF-driven angiogenesis at injury sites, and TB-500 (a thymosin beta-4 fragment) regulates actin to help repair cells migrate. The combination has not been tested as a blend in humans.
Storage — lyophilisedwhat's this?
Refrigerate 2-8C, protect from light.
Storage — reconstitutedwhat's this?
Refrigerate 2-8C, use within ~28 days.
Reconstitution noteswhat's this?
Most vials are 70 mg at a 5:1:1 ratio (50 mg GHK-Cu, 10 mg TB-500, 10 mg BPC-157). Common mix: 70 mg vial + 3 ml bacteriostatic water = about 23.3 mg/ml, so 10 units on a U-100 syringe (0.10 ml) is roughly 2,330 mcg of total blend. Always read the vial label — ratios vary by supplier.
Commonly stacked with
- KPV
- Wolverine stack (BPC-157 + TB-500)
Commonly reported side effects
- Injection-site stinging or redness
- Blue discolouration at the injection site
- Lightheadedness
- Nausea
Contraindications noted
- Wilson disease or copper overload
- Active malignancy (theoretical, via angiogenesis)
- Pregnancy or breastfeeding
Research notes
No published human trial has tested GHK-Cu + BPC-157 + TB-500 together; dosing is community-derived from the individual compounds. BPC-157 and TB-500 are WADA-prohibited for athletes.